STEAP3 is a new prognostic biomarker for ccRCC and exerts tumor‐promoting function via stimulating the invasion and EMT and inducing recruitment and polarization of M2 macrophages. The gene discussed is STEAP3; the disease is nonpapillary renal cell carcinoma.